Is Shukra Pharmaceuticals a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Shukra Pharmaceuticals Ltd is a below average quality company .

Is Shukra Pharmaceuticals undervalued or overvalued?

The key valuation ratios of Shukra Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Shukra Pharmaceuticals share price return in the past 10 years?

Shukra Pharmaceuticals Ltd share price has appreciated 48.5% annually (CAGR) over the past ten years.

Is Shukra Pharmaceuticals a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Shukra Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of Shukra Pharmaceuticals?

The latest standalone P/E ratio of Shukra Pharmaceuticals as of 17-Jun-2025 is 65.54.

What is the P/B ratio of Shukra Pharmaceuticals?

The latest standalone P/B ratio of Shukra Pharmaceuticals as of 17-Jun-2025 is 9.99.

What is the 52-week high and low of Shukra Pharmaceuticals?

The 52-week high of Shukra Pharmaceuticals is Rs. 27.15 and the 52-week low is Rs. 5.75.

Shukra Pharmaceuticals Ltd - Stock Valuation and Financial Performance

Name: Shukra Pharmaceuticals
Brand: Shukra Pharmaceuticals

BSE: 524632 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Shukra Pharma Share Price

₹14.05 -0.28 -1.95%
as on 17-Jun'25 16:59

10 Year X-Ray of Shukra Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	1.8%	2.4%	7.4%	5.9%	3.6%	0.8%	0.5%	5.8%	18.9%	44.2%	-
Value Creation Index ⓘ	-0.9	-0.8	-0.5	-0.6	-0.7	-1.0	-1.0	-0.6	0.4	2.2	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	2.6	4.8	5.1	5.3	5.7	11.9	11.2	20.5	58.8	74.6	33
Sales YoY Gr.	-	87.2%	6.4%	3.9%	6%	109.4%	-5.5%	83%	187.1%	26.8%	-
Adj EPS ⓘ	-0	0	0	0	0	0	0	0	0.1	0.4	0.2
YoY Gr.	-	NA	0%	0%	0%	-100%	NA	NA	400%	320%	-
BVPS (₹) ⓘ	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	1.6	1.3	1.4
Adj Net Profit ⓘ	-0.2	0.5	0.5	0.5	0.5	0	0.1	0.8	4.4	18.5	10
Cash Flow from Ops. ⓘ	-2	2.7	-0.3	0.8	0.3	1.2	0.5	8	3.2	-5.2	-
Debt/CF from Ops. ⓘ	-0.6	0	-0.1	4.3	23.4	6.5	18.2	0.4	1.6	-0.6	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	45.3%	67.5%	88.1%	26.8%
Adj EPS ⓘ	NA	83.8%	NA	320%
BVPSⓘ	12.4%	21%	36.4%	-18.5%
Share Price	48.5%	155.1%	196.3%	20.8%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	-1.1	3.6	3.5	3.6	3	-0.2	0.9	4.7	21.2	44.7	15.9
Op. Profit Mgn % ⓘ	-9.6	24.5	28.5	30.2	29.1	13	12.9	14.1	9.1	26	39.1
Net Profit Mgn % ⓘ	-6	10.4	9.8	9.9	8.2	-0.3	1.2	3.7	7.5	24.9	29.6
Debt to Equity ⓘ	0.1	0	0	0.2	0.4	0.5	0.6	0.2	0.2	0.1	0
Working Cap Days ⓘ	879	392	379	467	526	334	487	277	201	233	351
Cash Conv. Cycle ⓘ	165	75	64	31	40	39	132	54	-9	10	238

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 88.13%

Return on Equity has declined versus last 3 years average to 15.90%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at -45.93%

Latest Financials - Shukra Pharmaceuticals Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.2	-
TTM Sales (₹ Cr.)	32.6	-
BVPS (₹.) ⓘ	1.4	-
Reserves (₹ Cr.) ⓘ	19	-
P/BV ⓘ	9.99	-
PE ⓘ	65.54	-

From the Market
52 Week Low / High (₹)	5.75 / 27.15
All Time Low / High (₹)	0.00 / 27.15
Market Cap (₹ Cr.)	627
Equity (₹ Cr.)	43.8
Face Value (₹)	1
Industry PE ⓘ	41.7

Management X-Ray of Shukra Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Shukra Pharma

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

No data found!

Key Ratios of Shukra Pharma

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	3	5	5	5	6	12	11	20	59	75
Operating Expenses ⓘ	3	4	4	4	4	10	10	18	53	55
Manufacturing Costs	0	0	0	0	0	2	2	0	0	0
Material Costs	1	2	1	1	1	3	3	10	45	44
Employee Cost	1	1	1	1	2	4	4	5	4	5
Other Costs ⓘ	0	1	1	1	1	1	1	3	4	6
Operating Profit ⓘ	0	1	1	2	2	2	1	3	5	19
Operating Profit Margin (%)	-9.6%	24.5%	28.5%	30.2%	29.1%	13.0%	12.9%	14.1%	9.1%	26.0%
Other Income ⓘ	1	0	0	0	0	0	0	0	1	3
Interest ⓘ	0	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	1	0	0	1	1	1	1	2	2	2
Exceptional Items ⓘ	0	-1	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0	0	1	1	1	0	0	1	4	20
Tax ⓘ	0	0	1	0	0	0	0	0	0	1
Profit After Tax	0	0	1	1	0	0	0	1	4	19
PAT Margin (%)	5.1%	2.5%	9.8%	9.8%	8.2%	0.3%	1.7%	3.7%	7.5%	24.9%
Adjusted EPS (₹)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4
Dividend Payout Ratio (%)	0%	0%	16%	15%	17%	0%	0%	10%	4%	6%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	14	14	15	15	15	15	16	16	25	58
Share Capital ⓘ	2	2	2	2	2	2	2	2	4	11
Reserves ⓘ	12	13	13	13	14	14	14	15	21	47
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	1	0	0	4	6	8	10	3	4	3
Long Term Debt	1	0	0	4	6	8	10	3	4	3
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Trade Payables	1	1	1	2	3	6	5	9	34	7
Others Liabilities ⓘ	2	3	3	4	4	4	5	7	12	10
Total Liabilities ⓘ	18	17	19	24	28	34	36	35	75	78
Fixed Assets
Gross Block	20	20	21	26	29	32	34	35	40	41
Accumulated Depreciation	10	11	11	12	13	14	16	18	19	21
Net Fixed Assetsⓘ	10	10	10	14	16	17	18	18	20	20
CWIP ⓘ	2	2	2	2	2	2	2	2	2	2
Investmentsⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	1	0	0	0	0	1	2	4	3	2
Trade Receivables	1	1	2	3	5	8	10	7	30	25
Cash Equivalents	1	2	1	0	0	0	1	0	4	10
Others Assetsⓘ	4	3	4	5	5	5	4	4	16	19
Total Assets ⓘ	18	17	19	24	28	34	36	35	75	78

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	-2	3	0	1	0	1	1	8	3	-5
PBT ⓘ	3	0	1	1	1	0	0	1	4	20
Adjustment ⓘ	0	0	0	1	1	2	1	2	2	2
Changes in Working Capital ⓘ	-4	2	-1	-1	-1	-1	-1	5	-3	-26
Tax Paid ⓘ	0	0	0	0	0	0	0	0	0	-1
Cash Flow From Investing Activity ⓘ	1	0	-1	-5	-2	-3	-2	-2	-4	-1
Capex	1	0	-1	-5	-2	-3	-2	-2	-4	-2
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	1
Cash Flow From Financing Activityⓘ	1	-1	0	3	2	2	2	-7	5	12
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	5	14
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	2	-6	1	-1
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	1	-1	0	4	2	2	0	0	0	0
Net Cash Flow ⓘ	0	1	-1	0	0	0	0	0	4	6

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	0.94	0.85	3.51	3.55	3.04	0.23	1.21	4.7	21.16	44.7
ROCE (%)	1.83	2.4	7.41	5.94	3.62	0.77	0.54	5.79	18.85	44.24
Asset Turnover Ratio	0.14	0.27	0.28	0.27	0.25	0.44	0.32	0.58	1.07	0.98
PAT to CFO Conversion(x)	N/A	N/A	0	1	N/A	N/A	N/A	8	0.75	-0.26
Working Capital Days
Receivable Days	74	55	121	171	228	177	289	153	117	134
Inventory Days	172	67	27	15	11	22	50	50	22	13
Payable Days	255	97	245	526	872	563	762	246	170	168

Shukra Pharmaceuticals Ltd Stock News

Shukra Pharmaceuticals Ltd FAQs

What is the share price of Shukra Pharma?

Company share prices are keep on changing according to the market conditions. The closing price of Shukra Pharma on 17-Jun-2025 16:59 is ₹14.05.

What is the market cap of Shukra Pharma?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Jun-2025 16:59 the market cap of Shukra Pharma stood at ₹627.5.

What is the P/E ratio of Shukra Pharma?

The latest P/E ratio of Shukra Pharma as of 17-Jun-2025 16:59 is 65.54.

What is the P/B ratio of Shukra Pharma?

The latest P/B ratio of Shukra Pharma as of 17-Jun-2025 16:59 is 9.99.

What is the 52-week high and low of Shukra Pharma?

The 52-week high of Shukra Pharma is ₹27.15 and the 52-week low is ₹5.75.

What is the TTM revenue of Shukra Pharma?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Shukra Pharma is ₹32.59 ( Cr.) .

About Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals is an ambitious organisation with a deep rooted focus on sustainability with its impressive range of solutions. The company is committed to deliver excellence across National & Global markets. It is a public limited organisation with globally acclaimed manufacturing facilities.

The company is strongly committed to its values that guide it - The Shukra Group in serving the needs of its stakeholders including customers, suppliers, employees and other interest groups by large. Shukra stands for uncompromising quality and efficiency to deliver proven solutions delivered by passionate and motivated team of individuals.

The company boasts fully integrated structure for manufacturing general formulations like Tablet, Capsules and small volume parenteral since 2017. Along with internationally accredited facilities it invests in people.

The company has embarked upon its ambitious journey in the field of Pharamaceutical (date of inception) with a fully integrated plant in Rakanpor in Kalol, Gandhinagar - Gujarat. Since then, there was no looking back, within a short span of (years) the company has come a long way in making its mark in the sector.

The company has now developed an internationally accredited Laboratory in Ahmedabad where each product and solutions are developed under stringent quality processes.

Business area of the company

The company is engaged in the business of manufacturing and trading of pharmaceuticals Products, laboratory testing.

SEBI Registered: Investment Adviser - INA000013323 RIA Details

Warning: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Disclaimer: Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provides any assurance of returns to investors.

Compliance Officer:

Name: Shrikant Jagtap

Email: shrikant.jagtap@moneyworks4me.com

Mobile No: +91 97638 00745

Grievance Officer:

Name: Mukta Vaze

Email: mukta.vaze@moneyworks4me.com

Mobile No:+91 98609 19463

Principal Officer:

Name: Atharva Bhide

Email: atharva.bhide@moneyworks4me.com

Mobile No:+91 91758 99463

SEBI regional/local office address-

Plot No. C 4-A , G Block, Near Bank of India, Bandra Kurla Complex, Bandra East, Mumbai, Maharashtra 400051

Address:

The Alchemists Ark Pvt. Ltd., B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Data provided by Accord Fintech Pvt. Ltd.

Please wait your portfolio is updating...

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity - May 16, 2019 - Perpetual
BASL Membership ID:	BASL1187
Address	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Shukra Pharmaceuticals Ltd - Stock Valuation and Financial Performance

Shukra Pharma Share Price

DeciZen - make an informed investing decision on Shukra Pharma Share

Overall Rating ⓘ

1. Quality

2. Valuation ⓘ

3. Price Trend

Shukra Pharmaceuticals stock performance -

Is Shukra Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Shukra Pharmaceuticals Ltd a good quality company?

2. Is Shukra Pharmaceuticals Ltd undervalued or overvalued?

3. Is Shukra Pharmaceuticals Ltd a good buy now?

10 Year X-Ray of Shukra Pharma: Share

Analysis of Financial Track Record

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Recent Performance Summary

Latest Financials - Shukra Pharmaceuticals Ltd.

Management X-Ray of Shukra Pharma: Share

Shareholding Pattern

Promoter's Holding & Share Pledging